Stacy Sherrod
Executive Director
Last active: 12/17/2018


None provided


The following timeline graph is generated from all co-authored publications.

Featured publications are shown below:

  1. Untargeted Molecular Discovery in Primary Metabolism: Collision Cross Section as a Molecular Descriptor in Ion Mobility-Mass Spectrometry. Nichols CM, Dodds JN, Rose BS, Picache JA, Morris CB, Codreanu SG, May JC, Sherrod SD, McLean JA (2018) Anal Chem 90(24): 14484-14492
    › Primary publication · 30449086 (PubMed) · PMC6819070 (PubMed Central)
  2. Engineered microfluidic bioreactor for examining the three-dimensional breast tumor microenvironment. Rogers M, Sobolik T, Schaffer DK, Samson PC, Johnson AC, Owens P, Codreanu SG, Sherrod SD, McLean JA, Wikswo JP, Richmond A (2018) Biomicrofluidics 12(3): 034102
    › Primary publication · 29774083 (PubMed) · PMC5938175 (PubMed Central)
  3. Improving the discovery of secondary metabolite natural products using ion mobility-mass spectrometry. Schrimpe-Rutledge AC, Sherrod SD, McLean JA (2018) Curr Opin Chem Biol : 160-166
    › Primary publication · 29287234 (PubMed) · PMC5828964 (PubMed Central)
  4. In Utero Exposure to Histological Chorioamnionitis Primes the Exometabolomic Profiles of Preterm CD4 T Lymphocytes. Matta P, Sherrod SD, Marasco CC, Moore DJ, McLean JA, Weitkamp JH (2017) J Immunol 199(9): 3074-3085
    › Primary publication · 28947540 (PubMed) · PMC5659751 (PubMed Central)
  5. Integrated, High-Throughput, Multiomics Platform Enables Data-Driven Construction of Cellular Responses and Reveals Global Drug Mechanisms of Action. Norris JL, Farrow MA, Gutierrez DB, Palmer LD, Muszynski N, Sherrod SD, Pino JC, Allen JL, Spraggins JM, Lubbock AL, Jordan A, Burns W, Poland JC, Romer C, Manier ML, Nei YW, Prentice BM, Rose KL, Hill S, Van de Plas R, Tsui T, Braman NM, Keller MR, Rutherford SA, Lobdell N, Lopez CF, Lacy DB, McLean JA, Wikswo JP, Skaar EP, Caprioli RM (2017) J Proteome Res 16(3): 1364-1375
    › Primary publication · 28088864 (PubMed)
  6. Metabolic consequences of inflammatory disruption of the blood-brain barrier in an organ-on-chip model of the human neurovascular unit. Brown JA, Codreanu SG, Shi M, Sherrod SD, Markov DA, Neely MD, Britt CM, Hoilett OS, Reiserer RS, Samson PC, McCawley LJ, Webb DJ, Bowman AB, McLean JA, Wikswo JP (2016) J Neuroinflammation 13(1): 306
    › Primary publication · 27955696 (PubMed) · PMC5153753 (PubMed Central)
  7. Untargeted Metabolomics Strategies-Challenges and Emerging Directions. Schrimpe-Rutledge AC, Codreanu SG, Sherrod SD, McLean JA (2016) J Am Soc Mass Spectrom 27(12): 1897-1905
    › Primary publication · 27624161 (PubMed) · PMC5110944 (PubMed Central)
  8. Systems-Wide High-Dimensional Data Acquisition and Informatics Using Structural Mass Spectrometry Strategies. Sherrod SD, McLean JA (2016) Clin Chem 62(1): 77-83
    › Primary publication · 26453699 (PubMed) · PMC4843518 (PubMed Central)
  9. Wavelet-based peak detection and a new charge inference procedure for MS/MS implemented in ProteoWizard's msConvert. French WR, Zimmerman LJ, Schilling B, Gibson BW, Miller CA, Townsend RR, Sherrod SD, Goodwin CR, McLean JA, Tabb DL (2015) J Proteome Res 14(2): 1299-307
    › Primary publication · 25411686 (PubMed) · PMC4324452 (PubMed Central)